Pharm-ERA Doctoral Network

The contamination of global soil and aquatic ecosystems by pharmaceuticals, antimicrobial-resistant microorganisms, and pathogens is a pressing concern, threatening both our environment and human well-being. With the support of the Marie Skłodowska-Curie Actions programme, the Pharm-ERA project brings together academics, public and private stakeholders, and EU policymakers to address this urgent issue. With 10 doctoral projects spanning scientific disciplines such as environmental chemistry, ecotoxicology, microbial ecology, molecular biology and modelling, Pharm-ERA seeks to develop innovative solutions and improve monitoring techniques and environmental risk assessment. The ultimate aim is to protect the diversity and functions of microbial life in contaminated ecosystems while ensuring the sustainability of our planet and promoting human and animal health. Funded by the European Union under the Marie Skłodowska-Curie Actions Doctoral Networks and led by INRAE, Pharm-ERA consortium gathers 9 beneficiaries and 6 associated partners including a good balance between academia and non-academia sectors and offering a complete set of interdisciplinary skills for the project. COORDINATOR: INRAE, French National Research Institute for Agriculture, Food and Environment, France BENEFICIARIES : ● CEAB-CSIC, Center for Advanced Studies of Blanes - Spanish National Research Council, Spain ● IDAEA-CSIC, Institute of Environmental Assessment and Water Research - Spanish National Research Council, Spain ● KREATiS - Experts in Computational (Eco)Toxicology, France ● AEIFORIA SRL, Italy ● UFZ, Helmholtz Centre for Environmental Research, Germany ● UGOT, University of Gothenburg, Sweden ● UTH, University of Thessaly, Greece ● BETA Technological Centre, Spain ASSOCIATED PARTNERS: ● AquaBioTech Limited, Malta ● Swiss Centre for Applied Ecotoxicology, Switzerland ● Microbial Ecology Lab, France ● NATURALEA, Spain ● SmallOmics, Greece ● Fondation evertéa, France